ScholarLens Back to search
2005•The Journal of Heart and Lung TransplantationRequires access

Evidence for reduced SMAD signalling in diverse forms of pulmonary arterial hypertension (PAH)

Mark R. Southwood, Carl Atkinson, Simon Stewart, Richard C. Trembath, Nicholas W. Morrell

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: SMAD, BMPR2, Bone morphogenetic protein, Bone morphogenetic protein receptor, Cancer research, Receptor, Smad2 Protein, Phosphorylation

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Evidence for reduced SMAD signalling in diverse forms of pulmonary arterial hypertension (PAH) — Research Paper | ScholarLens